Northwest Biotherapeutics reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Agenus USD 1.02 1.32 Mar/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Celldex Therapeutics USD -0.96 0.02 Sep/2026
Eisai JPY 41.47 23.24 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Northwest Biotherapeutics USD -0.01 0 Mar/2026
Pfizer USD 0.87 0.1 Sep/2026
Plus Therapeutics USD -26.13 26.09 Mar/2026
Roche Holding CHF 10.98 2.61 Jun/2026